En el entorno neumológico no es habitual conocer las normativas europeas y de EE. UU.
que regulan la administración de oxígeno durante los viajes en avión y la política a tal …

No existe estudio que evalúe el estado de la oxigenoterapia en vuelo (OV) en nuestro país.
El objetivo de este estudio fue evaluar los requisitos, dificultades, sistemas y costos de la …

The authors conducted the largest prospective study into the outcomes of flights in patients
with various respiratory diseases, showing that 18% suffered respiratory symptoms. They …

Key points Commercial aircraft have a hypoxic environment, equivalent to an altitude of
2,438 m (8,000 ft) above sea level. Normal subjects and the majority of respiratory patients …

It is estimated that 1.5 to 4.5 billion passengers travel by air each year [1]. Flying at a high
altitude can induce significant hypoxemia in patients with underlying lung disease, despite …

There are currently 3.5 million people in Europe who require medical oxygen, and as life
expectancies increase, this figure is likely to grow. At the same time, air travel is becoming …

This study aimed to test the hypothesis that advice currently given by respiratory physicians
to potentially hypoxic patients planning air travel varies and is not evidence-based. A …

Background and objective: The aim of this study was to investigate the current
Australian/New Zealand airline policy on supplemental in‐flight oxygen for passengers with …

This report responds to a resolution that asked the American Medical Association (AMA) to
take action to improve airport and airline accommodations for passengers requiring medical …

For most passengers, even those with respiratory disease, air travel is safe and comfortable.
Some travelers may experience hypoxia at sea level but may not need supplemental oxygen …